Potential of circulating tumor DNA to refine immunotherapy.
作者信息
Lee Rebecca J, Luke Jason J
机构信息
University of Manchester, Manchester, UK.
The Francis Crick Institute, London, UK.
出版信息
Cancer. 2023 Jun 1;129(11):1646-1648. doi: 10.1002/cncr.34714. Epub 2023 Mar 4.
Abstract
摘要
相似文献
1
Potential of circulating tumor DNA to refine immunotherapy.循环肿瘤DNA优化免疫治疗的潜力
Cancer. 2023 Jun 1;129(11):1646-1648. doi: 10.1002/cncr.34714. Epub 2023 Mar 4.
2
Circulating Tumor DNA Dynamics: A New Approach in Revolutionizing Cancer Management.循环肿瘤DNA动态变化：癌症管理变革的新方法。
Ann Surg Oncol. 2024 Jan;31(1):163-164. doi: 10.1245/s10434-023-14452-w. Epub 2023 Oct 14.
3
Use of Circulating Tumor DNA for Cancer Immunotherapy.循环肿瘤 DNA 在癌症免疫治疗中的应用。
Clin Cancer Res. 2019 Dec 1;25(23):6909-6915. doi: 10.1158/1078-0432.CCR-18-2688. Epub 2019 Jul 8.
4
ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors.ctDNA：可切除实体瘤中新兴的新辅助生物标志物。
PLoS Med. 2021 Oct 12;18(10):e1003771. doi: 10.1371/journal.pmed.1003771. eCollection 2021 Oct.
5
Circulating Tumor DNA Biomarkers for Early Detection of Oligometastasis.循环肿瘤 DNA 生物标志物在寡转移早期检测中的应用。
Cancer J. 2020 Mar/Apr;26(2):116-123. doi: 10.1097/PPO.0000000000000437.
6
Cell-free circulating tumor DNA profiling in cancer management.癌症管理中的游离循环肿瘤DNA分析
Trends Mol Med. 2021 Oct;27(10):1014-1015. doi: 10.1016/j.molmed.2021.07.001. Epub 2021 Jul 24.
7
New cancer blood test developed.新型癌症血液检测方法研发成功。
Lancet Oncol. 2018 Mar;19(3):e140. doi: 10.1016/S1470-2045(18)30068-8. Epub 2018 Jan 26.
8
Hypermutated Circulating Tumor DNA: Correlation with Response to Checkpoint Inhibitor-Based Immunotherapy.高突变循环肿瘤 DNA：与基于检查点抑制剂免疫治疗反应的相关性。
Clin Cancer Res. 2017 Oct 1;23(19):5729-5736. doi: 10.1158/1078-0432.CCR-17-1439.
9
Reporting on circulating tumor DNA monitoring in metastatic cancer-From clinical validity to clinical utility.循环肿瘤 DNA 监测在转移性癌症中的报告——从临床有效性到临床实用性。
Cancer. 2022 Jun 1;128(11):2052-2057. doi: 10.1002/cncr.34168. Epub 2022 Mar 18.
10
Applications of Circulating Tumor DNA in a Cohort of Phase I Solid Tumor Patients Treated With Immunotherapy.循环肿瘤 DNA 在接受免疫治疗的 I 期实体瘤患者队列中的应用。
JNCI Cancer Spectr. 2021 Jan 23;5(3). doi: 10.1093/jncics/pkaa122. eCollection 2021 Jun.
引用本文的文献
1
Rapidly Evolving Pre- and Post-surgical Systemic Treatment of Melanoma.黑色素瘤的术前和术后系统治疗的快速发展。
Am J Clin Dermatol. 2024 May;25(3):421-434. doi: 10.1007/s40257-024-00852-5. Epub 2024 Feb 26.
本文引用的文献
1
Circulating tumor DNA-based molecular residual disease detection for treatment monitoring in advanced melanoma patients.基于循环肿瘤 DNA 的分子残留疾病检测在晚期黑色素瘤患者治疗监测中的应用。
Cancer. 2023 Jun 1;129(11):1723-1734. doi: 10.1002/cncr.34716. Epub 2023 Mar 4.
2
Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer.结直肠癌患者的分子残留疾病与辅助化疗疗效。
Nat Med. 2023 Jan;29(1):127-134. doi: 10.1038/s41591-022-02115-4. Epub 2023 Jan 16.
3
Comparing single-target and multitarget approaches for postoperative circulating tumour DNA detection in stage II-III colorectal cancer patients.比较 II-III 期结直肠癌患者术后循环肿瘤 DNA 检测的单靶点和多靶点方法。
Mol Oncol. 2022 Oct;16(20):3654-3665. doi: 10.1002/1878-0261.13294. Epub 2022 Aug 18.
4
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.循环肿瘤 DNA 分析指导 II 期结肠癌辅助治疗。
N Engl J Med. 2022 Jun 16;386(24):2261-2272. doi: 10.1056/NEJMoa2200075. Epub 2022 Jun 4.
5
Circulating tumour DNA monitoring and early treatment for relapse: views from patients with early-stage melanoma.循环肿瘤 DNA 监测与早期复发治疗：早期黑色素瘤患者的观点。
Br J Cancer. 2022 Jun;126(10):1450-1456. doi: 10.1038/s41416-022-01766-x. Epub 2022 Mar 17.
6
Circulating Tumor DNA Analysis and Functional Imaging Provide Complementary Approaches for Comprehensive Disease Monitoring in Metastatic Melanoma.循环肿瘤DNA分析与功能成像为转移性黑色素瘤的全面疾病监测提供了互补方法。
JCO Precis Oncol. 2017 Nov;1:1-14. doi: 10.1200/PO.16.00009.
7
Circulating Tumour DNA in Melanoma-Clinic Ready?循环肿瘤 DNA 在黑色素瘤中是否已准备好用于临床？
Curr Oncol Rep. 2022 Mar;24(3):363-373. doi: 10.1007/s11912-021-01151-6. Epub 2022 Feb 8.
8
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma.ctDNA 指导尿路上皮癌的辅助免疫治疗。
Nature. 2021 Jul;595(7867):432-437. doi: 10.1038/s41586-021-03642-9. Epub 2021 Jun 16.
9
ctDNA-Based Liquid Biopsy of Cerebrospinal Fluid in Brain Cancer.基于循环肿瘤DNA的脑癌脑脊液液体活检
Cancers (Basel). 2021 Apr 21;13(9):1989. doi: 10.3390/cancers13091989.
10
Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC).早期血浆循环肿瘤 DNA（ctDNA）变化可预测非小细胞肺癌（NSCLC）一线帕博利珠单抗治疗的反应。
J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-001504.
Zotero 插件